News

top news stories

ACI to Support the BARDA Accelerator Network’s Therapeutics and Vaccines Hub

May 9, 2024

Sensars secures EUR 1.1 million in funding to advance revolutionary neuromodulation technology

June 19, 2024

Simulatory successfully closed its seed equity round

June 12, 2024

S4DX GmbH has successfully closed €3.6M in a bridge financing round

May 6, 2024

Heart Failure start-up, Acorai, closes oversubscribed $4m funding round

January 16, 2024

Dr Reddy’s Laboratories acquires 6.46% stake in Edity Therapeutics for $2 million

December 29, 2023

Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines

December 5, 2023

TOLREMO therapeutics Completes $39 Million Series A Financing Round with Strategic Investment from Pierre Fabre Invest

September 20, 2023

Acorai starts Phase I clinical trial in Europe and the US

August 16, 2023

GoldTrack Graduate Launches Digital Pre-Analytical Monitoring System in Ten Countries in Europe

May 9, 2023

Press Releases

NovaSight introducing CureSight to U.S. market

Life-science consultancy Advice Connect Inspire, LLC reaches €500M raised by portfolio companies

Acorai starts Phase I clinical trial in Europe and the US

TOLREMO therapeutics Completes $39 Million Series A Financing Round with Strategic Investment from Pierre Fabre Invest

Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines

Dr Reddy’s Laboratories acquires 6.46% stake in Edity Therapeutics for $2 million

Heart Failure start-up, Acorai, closes oversubscribed $4m funding round

S4DX GmbH has successfully closed €3.6M in a bridge financing round

ACI to Support the BARDA Accelerator Network’s Therapeutics and Vaccines Hub

Want to massively scale your company?

Copyright © 2023 Advise Connect Inspire, LLC – All Rights Reserved.

Website by BKW Health